Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2139431 | Leukemia Research | 2008 | 8 Pages |
Abstract
Five out of nine relapses were preceded or were accompanied by minimally half log increased NPM/ALK levels in the BM. We found that RQ-RT-PCR of the CD30 expression is not suitable for MRD detection-only two relapses were accompanied by an increase of the CD30 level above a level which was detected in BM/PB samples from healthy individuals. RQ-RT-PCR of NPM/ALK expression is a promising and rapid approach for monitoring MRD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marketa Kalinova, Lenka Krskova, Helena Brizova, Edita Kabickova, Tomas Kepak, Roman Kodet,